Clinical Trials Browser

Adebrelimab × apatinib × 30 days × Clear all

NCT07353684 2026-04-22

Adebrelimab Plus Apatinib Combined With SOX Regimen as Conversion Therapy for Gastric Cancer

Phase 2 Recruiting

Gastrointestinal

Adebrelimab